Zonnic Nicotine Patches : Most Effective Nicotine Replacement Therapy or an Elaborate Scheme by Big
Tobacco?
Zonnic nicotine pouches entered the market in mid-October, sparking immediate controversy. The
Health Minister and health organizations have raised objections, while the manufacturer contends that
the product is unfairly maligned.
Crafted by Imperial Tobacco Canada, Zonnic nicotine pouches aim to serve as nicotine replacement
therapy (NRT) for smokers. Health Canada granted approval for their sale in July under Natural Health
Product Regulations, given their nicotine content without tobacco. Packaged in vibrant, “attractive-to-
youth” containers resembling gum. They come in three flavors: Tropic Breeze, Chill Mint, and Berry
Frost. Users place a pouch under their lip, releasing 4 mg of nicotine slowly. These pouches are available
in convenience stores, gas stations, and pharmacies.
Studies have found that oral nicotine pouches compared favorably to other NRTs, with users reporting
fewer minor adverse events and greater satisfaction than with nicotine lozenges or gum.
Despite these positive findings, six national health organizations have called for a change in regulations,
arguing that the approval was a mistake. They highlight concerns that Zonnic can be legally sold to
minors of any age and can be promoted through billboards, advertising, and free samples. Health
Canada, in response, emphasizes the importance of preventing youth access and is considering
regulatory options.
The health groups advocate for reclassifying Zonnic as a prescription product or banning its sale. They
also call for a temporary halt on approvals for similar nicotine pouches or new nicotine product
categories.
Imperial Tobacco Canada asserts that Zonnic targets adults and emphasizes self-regulation, ensuring
sales only to those over 18 with proof of age. However, health groups argue that, despite restrictions on
sales, there are no legal penalties for retailers selling it to minors.
The advertising approach is under scrutiny, with concerns that Zonnic's ads, emphasizing lifestyle, are
likely to reach children. Health Canada specifies that NRT labels and advertisements should prominently
indicate their intended use for smoking cessation in adults.
The Health Minister expresses concerns about the tobacco industry's intentions, while Imperial Tobacco
Canada defends Zonnic's efficacy and safety for smoking cessation. The ongoing debate raises parallels
with past challenges in regulating vaping, and health advocates stress the need for robust regulatory
frameworks to prevent potential risks associated with new nicotine products.

The medical information on this site is provided as an information resource only and is not to be used or relied on for any diagnostic or treatment purposes. This information does not substitute for professional diagnosis and treatment. Please do not initiate, modify, or discontinue any treatment, medication, or supplement solely based on this information. Always seek the advice of your health care provider first. Full Disclaimer